Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.
-
Upload
reginald-horton -
Category
Documents
-
view
222 -
download
0
Transcript of Perinatal Substance Abuse Denice Gardner, MSN, NNP-BC.
Perinatal Substance Abuse
Denice Gardner, MSN, NNP-BC
• Discuss Perinatal Substance Abuse and its affect on the newborn
Objectives
Pictures used in this presentation were obtained from the Mosby’s Nursing Consult web site
Tobacco/Nicotine Alcohol Stimulants Narcotics & Opioids Sedatives/Hypnotics Antidepressants
Categories of Drugs
Spontaneous abortion Placenta previa Placental abruption Preterm labor Premature rupture of membranes C-Section delivery Precipitous delivery Hypertension
Effects of Drugs on Pregnancy
Tobacco is a CNS stimulant Active components of cigarette smoke
Nicotine Tar Carbon monoxide Cyanide Plus, thousands of other compounds
Tobacco & Nicotine
Nicotine-water & fat soluble; cross the placenta
Carbon Monoxide- combines with hemoglobin & impairs oxygenation for mother & fetus; causes placental vasoconstriction & vasospasm
Dose/Response relationship- the higher the number of cigarettes smoked – the greater the effect on the fetus
Tobacco & Nicotine
Fetal/ Newborn Effects Intrauterine growth restriction Slight increase in risk for congenital
malformations Neurobehavioral effects Sudden Infant Death Syndrome Increased cost of hospitalization &
medical care Increased perinatal mortality
Tobacco & Nicotine
Nursing Considerations EDUCATION Follow infant’s growth Provide information regarding
smoking cessation programs & encourage participation
Tobacco & Nicotine
CNS depressant Absorbed rapidly through the stomach
& intestines; metabolized by the liver; excreted through the kidneys & lungs
Fetal alcohol is eliminated only after being broken down in the maternal liver
Diffuses across the placenta & impairs flow of nutrients to the fetus
Alcohol
Broken down into acetaldehyde & acetate. (Acetaldehyde is MORE toxic than alcohol).
Is a known teratogen Fetal effects are directly related to
dose, chronicity of use, gestational age, & duration of exposure
Alcohol
Fetal Alcohol Spectrum Disorder (FASD) Fetal Alcohol Syndrome (FAS) Partial Fetal Alcohol Syndrome Alcohol-Related Birth Defects (ARBD) Alcohol-Related Neurodevelopmental
Disorder (ARND)
Alcohol
Most severe form of FASD Most common identifiable cause of
mental retardation (also is a preventable cause)
Abnormalities in 3 domains Poor growth CNS abnormalities (developmental
delays, impaired brain growth, abnormal structure, etc.)
Dysmorphic facial features (thin, upper lip; smooth philtrum; short palpebral fissures, etc.)
Alcohol exposure may or may not be confirmed
Fetal Alcohol Syndrome
Fetal Alcohol Syndrome
Typical dysmorphic facial features Abnormality in one of the domains
CNS abnormality Growth Behavioral or cognitive ability
Confirmed prenatal alcohol exposure
Partial Fetal Alcohol Syndrome
Typical dysmorphic facial features Normal growth and brain
function/structure Congenital anomalies in other organs
(cardiac, skeletal, renal, eyes, ears) Confirmed prenatal alcohol exposure
Alcohol-Related Birth Defects (ARBD)
Absence of typical dysmorphic facial features
Normal Growth CNS abnormalities:
Decreased cranial size at birth Structural brain abnormalities Impairment of neurologic status in
relation to age Behavioral or cognitive abnormalities
inconsistent with age/developmental level
Confirmed prenatal alcohol exposure
Alcohol-Related Neurodevelopmental Disorder
(ARND)
Fetal Alcohol Syndrome
Begins anytime between birth & 12 hours after birth
Symptoms Tremors Hypertonia Opisthotonos Weak suck & poor feeding Sleeplessness Excessive crying Excessive mouthing behavior
Withdrawal from Alcohol
CocaineAmphetaminesCannabinoids
Stimulants
One of most powerful addictive substances
Is fat-soluble with low molecular weight so readily crosses blood-brain barrier & placenta
Rarely used alone Long half-life (can be present in
infant’s urine for up to 7 days of age)
Cocaine
Fetal/Newborn Effects No increase in congenital malformations Multi-organ dysfunction
CNS: abnormal sleep pattern, EEG, & cry; seizures/tremors; cerebral infarctions
Sensory organs: increased auditory startle response; abnormal ABR
Cardiac: arrhythmias; hypertension; decreased cardiac output
Cocaine
Fetal/Newborn Effects Multi-organ dysfunction (cont.)
Respiratory: apnea; periodic breathing
Renal: ectopiaGI: intestinal perforation; early-onset
NECEye: vascular, disruptive lesions;
retinal hemorrhage
Cocaine
Felt to be due to CNS irritability from effects of cocaine rather than from withdrawal
Initial period of hyperirritability followed by drowsiness &/or lethargy
Changes in behavioral state Difficulty responding to human
voice/face, comforting, &/or environmental stimuli
Difficulty maintaining alert states or rapid change is states
Hyperactive startle
Withdrawal from Cocaine
Used medically for treatment of narcolepsy, depression, weight loss, hyperactivity
Neurotoxic Fetal/Newborn effects:
IUGR
Amphetamines
Withdrawal from Amphetamines
Abnormal sleep patterns
Diaphoresis Vomiting after birth Agitation alternating
with lethargy Constriction of pupils High-pitched cry
Loose stools Yawning Fever Hyperreflexia
CNS- both depressant & mild hallucinogenic effects
High affinity for lipids & accumulates in fatty tissue of body
Placental transfer is greatest during first trimester of pregnancy
Results in increased carbon monoxide levels in blood causing hypoxia
Cannabinoids
Natural Opioids Morphine & Opium
Semi-synthetic Opioids Heroin & methadone
Synthetic Opioids Oxycodone, hydromorphone,
oxycodone, Fentanyl, etc.
Narcotics & Opioids
Fetal/Newborn Effects Readily crosses placenta Lower Apgar Scores Do NOT use naloxone for with
known/suspected narcotic & opioid dependence due to creation of rapid withdrawal & seizures
Meconium aspiration IUGR Lower incidence of RDS
Narcotics & Opioids
Congenital infections Increased incidence of SIDS Low birth weight Microcephaly Increased chromosomal
abnormalities in heroine-exposed infants
Narcotics & Opioids
Barbiturates Benzodiazepines
Sedatives/Hypnotics
Readily crosses placenta Fetal blood levels are similar to
maternal blood levels Accumulate in adipose tissue High concentration also present in
brain, lungs, & heart Fetuses exposed to long-term
benzodiazepines may have hypotonia, feeding difficulty, & withdrawal symptoms
Sedative/Hypnotics
Selective Serotonin Reuptake Inhibitors (SSRIs)
Sertaline (Zoloft), Fluoxetine (Prozac), Escitalopram (Lexapro), Paroxetine (Paxil), etc.
Tricyclic Antidepressants (TCAs) Amitriptyline (Elavil), Nortriptyline, etc.
Monoamine Oxidase Inhibitors (MAOIs)
Phenelzine (Nardil), Isocarboxazid (Marplan), etc.
Antidepressants
Onset may vary from shortly after birth to 2 weeks
Duration may range from 8 to 16 weeks Severity of presentation varies Infants of chronic drug abusers usually
have more severe withdrawal The closer to delivery the drug is taken,
the later the signs of withdrawal appear & the more severe the symptoms will be
Neonatal Abstinence Syndrome
Multiorgan/System Disorder Most common symptoms
Neurologic Increased toneTremorsExaggerated reflexes Irritability/restlessnessHigh-pitched cryDifficulty sleepingSeizures
Neonatal Abstinence Syndrome
Most common Symptoms Autonomic
YawningNasal stuffinessSweatingSneezingLow-grade feverMottling
Neonatal Abstinence Syndrome
Most Common Symptoms GI
Loose stoolsVomiting/regurgitationPoor feedingDifficulty swallowingExcessive sucking
Neonatal Abstinence Syndrome
Most Common Symptoms Respiratory
Tachypnea Others
Skin excoriation
Neonatal Abstinence Syndrome
Onset of withdrawal symptoms Alcohol- usually 3-12 hours after delivery Narcotics- usually 48-72 hours after
delivery, but may be as long as 4 weeks Barbiturates- usually 4-7 days after
delivery but can occur 1-14 days after delivery
Cocaine- usually 48-72 hours after delivery
Neonatal Abstinence Syndrome
Severity of NAS depends on The type of drug used Half-life of the drug Time of last exposure before
delivery Dose taken Quality of labor
Neonatal Abstinence Syndrome
Severity of NAS depends on Type of analgesia/anesthesia used
during labor Maturity & status of infant Gestational age Nutritional status of mother
Neonatal Abstinence Syndrome
Scoring Systems Modified Finnegan Scoring Tool
Gold Standard*** Neonatal Drug Withdrawal Scoring
System Neonatal Withdrawal Inventory
Neonatal Abstinence Syndrome
Screening Tools Maternal
Thorough history & assessmentDrug testing (urine is most
commonly used) Infant
Thorough assessmentUrine Drug screenMeconium Drug ScreenNewer testing: hair and umbilical
cord testing
Neonatal Abstinence Syndrome
Nursing Management Accurate assessment, evaluation, &
use if institution’s screening tool Comfort measures (swaddling, holding,
cuddling, response to stress cues, etc.) Assessment & encouragement of
mother/infant interaction Maternal/family support
Neonatal Abstinence Syndrome
Pharmacologic management Tincture of opium Camphorated Tincture of Opium
(Paregoric) Morphine (most common) Methadone Clonidine Chlorpromazine (Thorazine) Phenobarbital Diazepam
Neonatal Abstinence Syndrome
Breastfeeding Cigarettes:
not contraindicated encourage decreasing numbers of cigarettes smoked & smoking cessation
Smoke after breast feeding Alcohol: use should be discouraged
Neonatal Abstinence Syndrome
Breastfeeding Cocaine: contraindicated during
active use Marijuana: contraindicated Heroin: contraindicated Methadone: not contraindicated;
should not be stopped abruptly Sedatives/Hypnotics: dose-
dependent; discontinue with signs of lethargy &/or weight loss
Neonatal Abstinence Syndrome
Chang, G., Lockwood, C.J., & Barss. (2012). Substance Use In Pregnancy. Retrieved from www.uptodate.com on 8/17/2012.Sielski, L.A., Garcia-Prats, J.A., & Kim, M.S. (2012). Infants of Mothers with Substance Abuse. Retrieved from
www.uptodate.com on 8/17/2012.
References
Sielski, L.A., Garcia-Prats, J.A., & Kim, M.S. (2012). Neonatal Opioid Withdrawal
(Neonatal Abstinence Syndrome). `Retrieved from www.uptodate.com on 8/17/2012.
Verklan, M.T. & Walden, M. (2009). Core Curriculum for Neonatal Intensive Care Nursing (4rd Edition). Elseiver Saunders: St. Louis. Retrieved from Mosby’s Nursing
Consult web site on 6/16/2012.
References